The online pharmacy major SastaSundar which is a subsidiary of public-traded Microsec Financial Services Ltd, is planning to invest Rs.130 crore to expand its operation and is aiming to break even in 2017-18.
SastaSundar Chairman B L Mittal said that they have already turned into the largest online pharmacy servicing about 3,000 orders per day and they hope to break even in 2017-18.
He also said the company was planning to invest Rs.130 crore over the next one year to expand its footprint in Maharashtra and Bengaluru. 
Mittal said that presently the online pharmacy is servicing only in six districts of West Bengal as regulation restricts pharmacies to ship medicines out of the state unless the company has obtained drug license in the state where the drugs are supplied,
SastaSundar CEO Ravi Kant Sharma said the company had so far infused Rs.110 crore including manufacturing facility for FMCG products.
He also added that the company was moving towards bringing innovation in creating infrastructure to offer products and services tailored to an individual.
Sharma said that in a step toward bringing innovation, the company has introduced Dnavita, first in the history of health supplement industry. He said based on individual's health condition and nutrition requirement, Dnavita will be tailored and delivered to the customer.
"A customer has to provide details and interactions with the in house nutritionists, the health supplement will be customised and delivered in 3 days of order", Sharma said.
View Latest News: